Literature DB >> 23373769

The translocation of nuclear molecules during inflammation and cell death.

David S Pisetsky1.   

Abstract

SIGNIFICANCE: Inflammation is a complex biological process that represents the body's response to infection and/or injury. Endogenous molecules that induce inflammation are called death- or damage-associated molecular patterns (DAMPs). Among cellular constituents with DAMP activity, nuclear molecules can stimulate pattern recognition receptors, including toll-like receptors (TLRs). Current research is elucidating the translocation of nuclear molecules during cell death and identifying novel anti-inflammatory approaches to block their DAMP activity. RECENT ADVANCES: High mobility group box protein 1 (HMGB1), a non-histone nuclear protein, can translocate from cells during immune cell activation and cell death. Depending on redox state, HMGB1 can interact with TLR4 although it can bind to molecules such as cytokines to trigger other receptors. DNA and histones, which are bound together in the nucleus, also have important immunological activity. For DNA, DAMP activity may vary depending upon the binding to molecules that affect cell entry and intracellular location. The role of nuclear molecules in disease has been established in animal models using antibodies as inhibitors. CRITICAL ISSUES: Key issues about the DAMP activity of nuclear molecules relate to (i) the impact on function of biochemical modifications such as redox state and post-translational modification, and (ii) the composition and properties of complexes that nuclear molecules may form with other blood components to affect immunological activity. FUTURE DIRECTIONS: With the recognition of the immunological activity of the products of dead cells, future studies will define the diversity and properties of nuclear molecules in the extracellular space and develop strategies to block their activity during inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23373769      PMCID: PMC3928723          DOI: 10.1089/ars.2012.5143

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  66 in total

1.  High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.

Authors:  Hulda Sigridur Hreggvidsdóttir; Anna M Lundberg; Ann-Charlotte Aveberger; Lena Klevenvall; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.

Authors:  Ju Ho Youn; Jeon-Soo Shin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  DAMPs, PAMPs and alarmins: all we need to know about danger.

Authors:  Marco E Bianchi
Journal:  J Leukoc Biol       Date:  2006-10-10       Impact factor: 4.962

4.  Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Authors:  Huan Yang; Peter Lundbäck; Lars Ottosson; Helena Erlandsson-Harris; Emilie Venereau; Marco E Bianchi; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Daniel J Antoine
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

5.  Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils.

Authors:  Ichiaki Ito; Jutarou Fukazawa; Michiteru Yoshida
Journal:  J Biol Chem       Date:  2007-04-02       Impact factor: 5.157

6.  Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).

Authors:  Ari Rouhiainen; Sarka Tumova; Leena Valmu; Nisse Kalkkinen; Heikki Rauvala
Journal:  J Leukoc Biol       Date:  2006-09-15       Impact factor: 4.962

7.  The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid.

Authors:  Weiwen Jiang; Charles W Bell; David S Pisetsky
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

8.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.

Authors:  Akinori Takaoka; Zhichao Wang; Myoung Kwon Choi; Hideyuki Yanai; Hideo Negishi; Tatsuma Ban; Yan Lu; Makoto Miyagishi; Tatsuhiko Kodama; Kenya Honda; Yusuke Ohba; Tadatsugu Taniguchi
Journal:  Nature       Date:  2007-07-08       Impact factor: 49.962

9.  Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

Authors:  Jane Tian; Ana Maria Avalos; Su-Yau Mao; Bo Chen; Kannaki Senthil; Herren Wu; Peggy Parroche; Stacey Drabic; Douglas Golenbock; Cherilyn Sirois; Jing Hua; Ling Ling An; Laurent Audoly; Greg La Rosa; Angelika Bierhaus; Peter Naworth; Ann Marshak-Rothstein; Mary K Crow; Katherine A Fitzgerald; Eicke Latz; Peter A Kiener; Anthony J Coyle
Journal:  Nat Immunol       Date:  2007-04-08       Impact factor: 25.606

10.  Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.

Authors:  Anna Rubartelli; Michael T Lotze
Journal:  Trends Immunol       Date:  2007-09-12       Impact factor: 16.687

View more
  27 in total

1.  High-mobility group box 1 inhibits HCO3- absorption in the medullary thick ascending limb through RAGE-Rho-ROCK-mediated inhibition of basolateral Na+/H+ exchange.

Authors:  Bruns A Watts; Thampi George; Andrew Badalamenti; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-29

Review 2.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

Review 3.  Complexity of danger: the diverse nature of damage-associated molecular patterns.

Authors:  Liliana Schaefer
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 4.  The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo.

Authors:  David S Pisetsky
Journal:  Mol Med       Date:  2014-04-01       Impact factor: 6.354

5.  High-Mobility Group Box 1 Neutralization Prevents Chronic Cerebral Hypoperfusion-Induced Optic Tract Injuries in the White Matter Associated with Down-regulation of Inflammatory Responses.

Authors:  Yue Hei; Xin Zhang; Rong Chen; Yuefei Zhou; Dakuan Gao; Weiping Liu
Journal:  Cell Mol Neurobiol       Date:  2019-06-13       Impact factor: 5.046

Review 6.  Review: Cell Death, Nucleic Acids, and Immunity: Inflammation Beyond the Grave.

Authors:  Keith B Elkon
Journal:  Arthritis Rheumatol       Date:  2018-04-18       Impact factor: 10.995

7.  High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.

Authors:  David W Good; Thampi George; Bruns A Watts
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-15

Review 8.  Antinuclear antibody testing - misunderstood or misbegotten?

Authors:  David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2017-05-25       Impact factor: 20.543

9.  The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells.

Authors:  Anirudh J Ullal; Tony N Marion; David S Pisetsky
Journal:  Clin Immunol       Date:  2014-05-27       Impact factor: 3.969

Review 10.  The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE.

Authors:  David S Pisetsky
Journal:  Autoimmunity       Date:  2014-06-11       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.